Novo Nordisk Pill Targets New Market as GLP-1 Hype Peaks
A cynical analysis of Novo Nordisk’s new Wegovy pill launch. Is it a health breakthrough, or a calculated market move by Big Pharma to secure profit before competitors arrive?
Ideas meet Information
A cynical analysis of Novo Nordisk’s new Wegovy pill launch. Is it a health breakthrough, or a calculated market move by Big Pharma to secure profit before competitors arrive?
Unmasking the annual flu season scare. Is it public health or profit? A cynical look at rising cases, CDC data, and the manufactured panic driving pharmaceutical gains.